|
Chairman
 Rick
Randall
Chairman 2008
Rick Randall is the President and CEO of TranS1, Inc, a company dedicated to developing and marketing minimally invasive therapies to treat lower back pain.
Rick served as President and CEO of Innovasive Devices, Inc. from 1994 to 2000, when the firm was acquired by the Ethicon Division of Johnson & Johnson. Innovasive Devices was a developer, manufacturer and marketer of arthroscopic surgical products.
From 1989 to 1996 Rick served as President, Chairman and Director of Target Therapeutics, Inc., a medical device company serving the interventional neurosurgery market. Target was acquired by Boston Scientific, Inc in 1997. Prior to Target, he held various sales and marketing management positions with Trimedyne, Inc., Baxter Edwards and the USCI Division of C.R. Bard, Inc.
He is also co-founder of Conceptus, Inc. and Cardima, Inc., and is a Director of AbbeyMoor Medical and TissueLink Medical.
Rick earned a Bachelor of Science degree from State University College at Buffalo, Buffalo, NY.
Board of Directors
David R. Stern
SEMDA President
David Stern is currently the Sr. Vice President of Scientific Affairs and a
member of the board of directors for CardioMEMS, Inc., an Atlanta based medical
device company that has developed proprietary wireless sensing and communication
technology designed to improve the management of chronic diseases.
David previously served as Vice President and Business Unit Manager of the
Peripheral Technologies Division of C.R. Bard. He holds a B.S. in Biomedical
Engineering from Rensselaer Polytechnic Institute and a M.E. in Biomedical
Engineering from Worcester Polytechnic Institute.
Tom Brooks
Tom Brooks is a serial entrepreneur with over 22 years of medical device and healthcare experience. He was one of the founding members of a new division of Ethicon, Endo-Surgery, a Johnson & Johnson company. He led Boston Scientific’s Business Development team into four new markets from 1986 to 1994. He was one of the original members of the senior management team for Novoste Corporation in Atlanta from 1995 until1999 when he left to start a healthcare IT company. In April 2000, he sold the healthcare IT company he founded with a physician. In 2001, he joined Conor Medsystems, a drug delivery company. As President, he helped raise multiple rounds of funding before leaving to start Healthcare Capital Partners, a Venture Capital fund, in August 2003.
Tom is Managing Partner for HealthCare Capital Partners, an Atlanta-based Venture Capital firm specializing in making seed and early-stage investments in healthcare companies, including medical technology, medical devices and diagnostics. Typical investments are: (1) between $150,000 to $1.5 million initially, reaching a total investment of $1 to $4 million in any one company; (2) syndicated with other leading venture capital firms throughout the country; and (3) located in the Southeastern U.S.
Albert "Ace" C. Edwards
SEMDA Treasurer
Ace has been involved in the electronics industry for the past thirty years, the past seven in medical devices. Currently he provides independent design/engineering & product fabrication services to manufacturers. Prior to providing independent services he was the Director of Sales, Marketing, and Business Development at Sector Electronics and Sector Medical Corp. Sector Electronics provides high level electronic design/engineering services predominantly to medical device companies. Sector Medical was a start-up medical device company that developed and marketed a screening device for Obstructive Sleep Apnea. During this time he also started a Home Health Agency providing in-home care for seniors.
Prior to working with Sector he spent sixteen years working for a fortune 200 company in electronic interconnection systems. He worked up through the sales ranks to the position of National Sales Manager and the Director of Global Marketing.
Ace holds a bachelors degree in Industrial Management from the Georgia Institute of Technology and his master’s degree in Business and Entrepreneurship from Wake Forest Babcock School of Management.
 John G. Edwards
John Edwards is founder and CEO of Apeliotus Technologies, a medical device company that develops and commercializes products based on innovations from universities in the Southeast.
John has been involved in technology commercialization for more than 25 years at four successful university spin-off companies and a major university research lab.
John holds SB and SM degrees in physics from MIT and an MBA from the University of Chicago.
 Paul Gianneschi
SEMDA Past President
Paul Gianneschi is the Managing Principal and Founder of Hatch Medical, L.L.C., a privately held medical device incubator and technology brokerage firm focused on assisting physician inventors, entrepreneurs and early-stage companies with minimally invasive medical device technologies.
Paul has spent the past 17 years as an executive in the healthcare industry. Prior to founding Hatch Medical in 2000, Paul served over seven years in a series of senior level marketing and sales management positions with medical device industry leader, C. R. Bard, Inc.'s Peripheral Vascular Division. Prior to joining Bard, Paul worked in similar capacities with Bausch & Lomb and NDC Health / McKesson.
Paul earned a Bachelor of Science degree from the University of Florida and an M.B.A. in International Management from Mercer University, where he currently serves on the board of their business school.
 David
B. Hartnett
David Hartnett is Vice President, Economic Development for the Metro Atlanta Chamber of Commerce, specializing in high tech and bioscience. He has more than 19 years of senior management, Medical Device/Pharmaceutical, and Telemedicine - IT healthcare experience with early stage to publicly traded companies.
David’s diverse experience has contributed to the success of six premier medical device companies receiving international recognition. He has served as a lead in the management, development and commercialization of over 14 medical devices, ranging in classification.
Prior experience includes Managing Director of Medical Device Marketing® and President and Chief Executive Officer of UnitedPharma®. He has also held positions as President, CEO of SteriFx® Corporation, Given Imaging, Inc. ERBE Electrosurgery, Karl Storz Lithotripsy, Genzyme® (formerly Deknatel), STERIS® (formerly AMSCO®) and the XEROX® Corporation.
David holds a B.Sc. in Speech Communication, from San Diego State University with a master’s equivalent in Marketing through Post Graduate executive management studies.
Charlie
Harrison
Charlie Harrison, President and CFO of Wynden Pharmaceuticals, Inc., brings 35 years of marketing and operating experience in driving new product and business commercialization in pharmaceutical, device and biotech markets.
Prior to founding Wynden, Charlie was founder and President of Critical Strategies, LLC, providing business development and strategic advisory support to life science companies. Prior to Critical Strategies, Charlie served in a series of senior management roles with Serologicals, Creative Product Resource, Unimed, SmithKline (now GSK) and Organon (now Schering).
Charlie serves on the Boards of the American-Israel Chamber of Commerce, Southeast Region and Medical Compression Systems Ltd., a public Israel-based medical device company. Charlie received his BS in Mathematics from Pennsylvania State University and his MBA from the University of Massachusetts.
 Lynn
Hood
Lynn Hood, President of Hood Marketing Solutions, has more than 25 years of experience working with agencies and corporations in marketing and communications. For two decades her agency, Hood Marketing Solutions, has built a track record of helping companies strategically position themselves in the marketplace and increase sales through innovative, cost-effective marketing techniques. The agency specializes in high tech, bioscience and business-to-business marketing.
Lynn is active in a number of organizations that support Atlanta’s growth. She is a founding member of SEMDA and Chairman of the Branding Subcommittee for the Metro Atlanta Chamber of Commerce’s Technology Marketing Initiative. Lynn is actively involved with Georgia Bio and is on the Advisory Board of its Emerging Leaders Network. She also serves as marketing chair for the MIT Enterprise Forum of Atlanta and is a member of the Technology Association of Georgia. She is a long-time member of the Marketing Advisory Board for the Center for the Visually Impaired.
 Rick
Haury
Richard L. Haury Jr. is a partner in the corporate, healthcare, securities and medical device practice groups. His principal areas of practice are healthcare, corporate transactions. He has extensive experience representing healthcare providers and companies in regulatory and business matters that include advising healthcare entities in corporate structuring, joint ventures and mergers and acquisitions; providing guidance regarding financing and capitalization of new ventures and providing corporate, financing and regulatory guidance to medical device companies. Mr. Haury is a co-founder and former president of the Southeastern Medical Device Association (SEMDA) and is recognized among the leaders in his field in the Atlanta Business Chronicle’s Who’s Who in Healthcare. Mr. Haury holds a B.B.A. from Emory University a J.D. from Vanderbilt University and an M.B.A. from The Owen Graduate School of Management, Vanderbilt.
 Gerard van Hamel Platerink
Gerard van Hamel Platerink is Managing Director of Accuitive Medical Ventures (AMV), a venture capital firm with committed capital of $230 million and offices in Atlanta, GA and Rochester, MN. AMV is in business to finance and help develop early stage medical technology and device companies.
Prior to joining AMV at the time of its foundation, Gerard worked at Novoste Corporation, the cardiovascular brachytherapy company, in business development and corporate communications. Before joining Novoste, Gerard was in the Healthcare Group of Salomon Brothers (now Citigroup) in London, where he focused on investments and transactions in the medical device sector. He began his career with Kleinwort Benson, where he was an investment banker and member of the bank's private equity and mezzanine finance group.
Gerard is a Dutch national, was born in Borneo in Southeast Asia, grew up in Africa and was educated in the UK where he got his BS in Physics from St. Andrews University and an MBA from Cambridge University.
Gerard is a co-founder of Halscion and currently has board responsibilities for Halscion, Axogen, Neuronetics, NeoVista, WaveTec and AqueSys.
|
Save the Date:
SEMDA 2009 Annual Conference, Tuesday, February 10, 2009 at Georgia Aquarium
